tradingkey.logo
tradingkey.logo
Buscar

Inogen Inc

INGN
Añadir a la lista de seguimiento
6.600USD
-0.050-0.75%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
179.73MCap. mercado
PérdidaP/E TTM

Más Datos de Inogen Inc Compañía

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Información de Inogen Inc

Símbolo de cotizaciónINGN
Nombre de la empresaInogen Inc
Fecha de salida a bolsaFeb 14, 2014
Director ejecutivoSmith (Kevin R. M)
Número de empleados766
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 14
Dirección859 Ward Drive
CiudadGOLETA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal93111
Teléfono18055620500
Sitio Webhttps://www.inogen.com/
Símbolo de cotizaciónINGN
Fecha de salida a bolsaFeb 14, 2014
Director ejecutivoSmith (Kevin R. M)

Ejecutivos de Inogen Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
74.35K
+37.77%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
74.35K
+37.77%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
37.19K
+75.50%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Mr. Ryan Peterson
Mr. Ryan Peterson
Associate Director - Investor Relations
Associate Director - Investor Relations
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
74.35K
+37.77%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
74.35K
+37.77%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
37.19K
+75.50%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Inogen Inc?

Los cinco principales accionistas de Inogen Inc son: Mr. Michael J. Bourque

¿Cuántas instituciones poseen acciones de Inogen Inc (INGN)?

A fecha de 2026Q1, 294 instituciones poseen acciones de Inogen Inc, con un valor de mercado combinado de aproximadamente 20.74M, lo que representa el 75.89% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -3285676.00.